July 11 (Reuters) - Mink Therapeutics Inc INKT.O:
MINK THERAPEUTICS ANNOUNCES PUBLICATION OF COMPLETE REMISSION FOLLOWING ALLOGENEIC INKT CELL THERAPY IN METASTATIC TESTICULAR CANCER
Source text: ID:nGNX20zmcj
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))